Tata India Pharma & Healthcare Fund vs UTI Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1339 Cr | ₹1126 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 28 Dec 2015 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare |
| Turn Over | 26.49% | 28% |
| Expense Ratio | 2.14 | 2.22 |
| Manager | Meeta Shetty | Kamal Gada |
| ISIN Code | INF277K016A9 | INF789F01695 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | -1.46% | -1.04% |
| 6 Month | 1.52% | 0.86% |
| 1 Year | -0.19% | -0.37% |
| 3 Year | 21.93% | 24.07% |
| 5 Year | 15.94% | 15.8% |
SIP Return Analysis
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | -1.22% | -1.84% |
| 1 Year | 4.63% | 5.72% |
| 3 Year | 17.22% | 19.68% |
| 5 Year | 16.69% | 17.73% |
Rolling Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 8.63% | 11.65% |
| 3 Year | 18.84% | 16.53% |
| 5 Year | 15.73% | 14.78% |
Risk Management
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 16.04% | 15.79% |
| Sharp | 0.91% | 1.02% |
| Beta | 0.98% | 0.95% |
| Alpha | -1.01% | 1.02% |
Fund Managers
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Meeta Shetty | Kamal Gada |
| Total AUM | ₹17847 Cr | ₹870 Cr |
| Funds Managed | 5 | 1 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 3.86 | 5.77 |
| Mid Cap | 38.84 | 34.95 |
| Small Cap | 34.36 | 38.55 |
| Large Cap | 22.93 | 20.74 |
Sector Allocation
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.5 | 1.25 |
| Healthcare | 96.33 | 97.71 |
| Basic Materials | 2.17 | 1.03 |
| Financial Services | 0 | - |
Top Comparisons
Bajaj Finserv Overnight Fund Regular - Growth
3Y Returns0%
Aditya Birla Sun Life Overnight Fund-Regular Plan-Growth
3Y Returns6.31%
Franklin U.S. Opportunities Equity Active FOF - Regular - Growth
3Y Returns23.22%
DSP World Mining Overseas Equity Omni FOF - Regular Plan - Growth
3Y Returns16.91%
HDFC Equity Savings Fund - GROWTH PLAN
3Y Returns9.98%
UTI Conservative Hybrid Fund - Regular Plan - Growth Option
3Y Returns10.7%
ICICI Prudential Money Market Fund Option - Growth
3Y Returns7.52%
Nippon India Money Market Fund-Growth Plan-Growth Option
3Y Returns7.52%